These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8831753)

  • 1. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 2. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2.
    Beaton HG; Bennion C; Connolly S; Cook AR; Gensmantel NP; Hallam C; Hardy K; Hitchin B; Jackson CG; Robinson DH
    J Med Chem; 1994 Mar; 37(5):557-9. PubMed ID: 8126692
    [No Abstract]   [Full Text] [Related]  

  • 5. Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor.
    Mouchlis VD; Mavromoustakos TM; Kokotos G
    J Comput Aided Mol Des; 2010 Feb; 24(2):107-15. PubMed ID: 20130961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third calcium ion found in an inhibitor-bound phospholipase A2.
    Sekar K; Gayathri D; Velmurugan D; Jeyakanthan J; Yamane T; Poi MJ; Tsai MD
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):392-7. PubMed ID: 16552140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution.
    Jabeen T; Singh N; Singh RK; Sharma S; Somvanshi RK; Dey S; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2005 Dec; 61(Pt 12):1579-86. PubMed ID: 16301791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.
    Smart BP; Oslund RC; Walsh LA; Gelb MH
    J Med Chem; 2006 May; 49(10):2858-60. PubMed ID: 16686528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.
    Kitadokoro K; Hagishita S; Sato T; Ohtani M; Miki K
    J Biochem; 1998 Apr; 123(4):619-23. PubMed ID: 9538252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius.
    Jain MK; Yu BZ; Rogers JM; Smith AE; Boger ET; Ostrander RL; Rheingold AL
    Phytochemistry; 1995 Jun; 39(3):537-47. PubMed ID: 7576451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
    Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M
    J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational modification of human synovial fluid phospholipase A2 inhibitors.
    Pisabarro MT; Ortiz AR; Palomer A; Cabré F; García L; Wade RC; Gago F; Mauleón D; Carganico G
    J Med Chem; 1994 Feb; 37(3):337-41. PubMed ID: 8308860
    [No Abstract]   [Full Text] [Related]  

  • 15. Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition.
    Georgieva DN; Rypniewski W; Gabdoulkhakov A; Genov N; Betzel C
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1314-21. PubMed ID: 15194511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.
    Hansford KA; Reid RC; Clark CI; Tyndall JD; Whitehouse MW; Guthrie T; McGeary RP; Schafer K; Martin JL; Fairlie DP
    Chembiochem; 2003 Mar; 4(2-3):181-5. PubMed ID: 12616631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray crystal structure and molecular dynamics simulation of bovine pancreas phospholipase A2-n-dodecylphosphorylcholine complex.
    Tomoo K; Ohishi H; Ishida T; Inoue M; Ikeda K; Sumiya S; Kitamura K
    Proteins; 1994 Aug; 19(4):330-9. PubMed ID: 7984628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of rational design on phospholipase A(2) inhibitors.
    Mouchlis VD; Barbayianni E; Mavromoustakos TM; Kokotos G
    Curr Med Chem; 2011; 18(17):2566-82. PubMed ID: 21568891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
    Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
    Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.